Variable | Controls (N = 910) | Clinical DLB (N = 360) | LBD with a high likelihood of DLB (N = 446) |
---|---|---|---|
Age (years)a | 79 (41, 102) | 73 (50, 100) | 78 (48, 103) |
Sex | |||
Male | 388 (42.6%) | 270 (75.0%) | 292 (65.5%) |
Female | 522 (57.4%) | 90 (25.0%) | 154 (34.5%) |
Braak NFT stage | |||
0 | N/A | N/A | 13 (2.9%) |
I | N/A | N/A | 23 (5.2%) |
II | N/A | N/A | 138 (30.9%) |
III | N/A | N/A | 143 (32.1%) |
IV | N/A | N/A | 129 (28.9%) |
V | N/A | N/A | 0 (0.0%) |
VI | N/A | N/A | 0 (0.0%) |
Thal amyloid phase | |||
0 | N/A | N/A | 40 (10.7%) |
1 | N/A | N/A | 37 (9.9%) |
2 | N/A | N/A | 23 (6.1%) |
3 | N/A | N/A | 129 (34.4%) |
4 | N/A | N/A | 56 (14.9%) |
5 | N/A | N/A | 90 (24.0%) |
LBD subtype | |||
Transitional | N/A | N/A | 89 (20.0%) |
Diffuse | N/A | N/A | 357 (80.0%) |
Lewy body counts | |||
Middle frontal gyrus | N/A | N/A | 5 (0, 35) |
Superior temporal gyrus | N/A | N/A | 10 (0, 50) |
Inferior parietal gyrus | N/A | N/A | 4 (0, 30) |
Cingulate gyrus | N/A | N/A | 12 (2, 32) |
Parahippocampal gyrus | N/A | N/A | 16 (1, 45) |
Putaminal TH-ir | |||
Dorsolateral | N/A | N/A | 2.93 (0.26, 21.61) |
Ventromedial | N/A | N/A | 8.99 (0.26, 27.42) |
Substantia nigra neuronal loss score | |||
Ventrolateral | |||
 0.0 = none | N/A | N/A | 0 (0.0%) |
 0.5 = none/mild | N/A | N/A | 2 (1.0%) |
 1.0 = mild | N/A | N/A | 10 (5.1%) |
 1.5 = mild/moderate | N/A | N/A | 7 (3.6%) |
  2.0 = moderate | N/A | N/A | 21 (10.8%) |
 2.5 = moderate/severe | N/A | N/A | 23 (11.8%) |
 3.0 = severe | N/A | N/A | 132 (67.7%) |
Medial | Â | Â | Â |
 0.0 = none | N/A | N/A | 2 (1.1%) |
 0.5 = none/mild | N/A | N/A | 1 (0.6%) |
 1.0 = mild | N/A | N/A | 25 (14.0%) |
 1.5 = mild/moderate | N/A | N/A | 16 (8.9%) |
 2.0 = moderate | N/A | N/A | 26 (14.5%) |
 2.5 = moderate/severe | N/A | N/A | 25 (14.0%) |
 3.0 = severe | N/A | N/A | 84 (46.9%) |